Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
NXTC

Updated 10/6/2026, 8:26 AM ET.

NXTC

NextCure, Inc.

Sale$184,800

Simcere Zaiming, Inc.

Insider

and 5 others

30,000 shat $6.16Filed Aug 12, 11:35 AM ETFiling
NXTC

NextCure, Inc.

Buy$1,624,121

ADAR1 Capital Management, LLC

10% owner

and 1 other

329,153 shat $4.93Filed Aug 3, 5:53 PM ETFiling
NXTC

NextCure, Inc.

Buy$87,713

ADAR1 Capital Management, LLC

10% owner

and 1 other

17,608 shat $4.98Filed Jul 29, 6:18 PM ETFiling

Read from public SEC filings. Not financial advice.